checkAd

     634  0 Kommentare Medigene appoints Dr. Thomas Taapken as Chief Financial Officer - Seite 3

    Contact Medigene
    Julia Hofmann, Dr. Robert Mayer
    Tel.: +49 - 89 - 20 00 33 - 33 01
    Email: investor@medigene.com

    Should you no longer wish to receive any information about Medigene, please inform us by e-mail (investor@medigene.com). We will then delete your address from our distribution list.




    This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: Medigene AG via Globenewswire

    Lesen Sie auch

    --- End of Message ---

    Medigene AG
    Lochhamer Strasse 11 Martinsried / München Germany

    WKN: A1X3W0;ISIN: DE000A1X3W00;
    Listed: Freiverkehr in Börse Stuttgart,
    Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
    Freiverkehr in Börse Berlin,
    Freiverkehr in Börse Düsseldorf,
    Freiverkehr in Bayerische Börse München,
    Freiverkehr in Niedersächsische Börse zu Hannover,
    Prime Standard in Frankfurter Wertpapierbörse,
    Regulierter Markt in Frankfurter Wertpapierbörse;


    Seite 3 von 3


    Diskutieren Sie über die enthaltenen Werte


    GlobeNewswire
    0 Follower
    Autor folgen

    Verfasst von GlobeNewswire
    Medigene appoints Dr. Thomas Taapken as Chief Financial Officer - Seite 3 Medigene AG / Medigene appoints Dr. Thomas Taapken as Chief Financial Officer . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Dr. Taapken contributes significant …

    Schreibe Deinen Kommentar

    Disclaimer